Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
American Shared Hospital Service (AMS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: AMS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -29.91% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.75M USD | Price to earnings Ratio 11.63 | 1Y Target Price 4.85 |
Price to earnings Ratio 11.63 | 1Y Target Price 4.85 | ||
Volume (30-day avg) - | Beta 0.29 | 52 Weeks Range 2.30 - 4.60 | Updated Date 06/29/2025 |
52 Weeks Range 2.30 - 4.60 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.21 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.93% | Operating Margin (TTM) -14.17% |
Management Effectiveness
Return on Assets (TTM) 0.71% | Return on Equity (TTM) 2% |
Valuation
Trailing PE 11.63 | Forward PE 7.58 | Enterprise Value 32553125 | Price to Sales(TTM) 0.54 |
Enterprise Value 32553125 | Price to Sales(TTM) 0.54 | ||
Enterprise Value to Revenue 1.11 | Enterprise Value to EBITDA 4.15 | Shares Outstanding 6450000 | Shares Floating 3419790 |
Shares Outstanding 6450000 | Shares Floating 3419790 | ||
Percent Insiders 49.7 | Percent Institutions 13.91 |
Upturn AI SWOT
American Shared Hospital Service
Company Overview
History and Background
American Shared Hospital Services (AMS) was founded in 1980. It provides medical technology solutions to hospitals and healthcare providers, primarily focusing on radiosurgery and radiation therapy equipment and services.
Core Business Areas
- Radiosurgery: Provides stereotactic radiosurgery and radiation therapy equipment and services to hospitals and cancer centers.
- Radiation Therapy: Offers radiation therapy equipment such as proton beam radiation therapy systems.
- Equipment Leasing: Leases advanced medical equipment to healthcare facilities.
Leadership and Structure
Ernest A. Bates, M.D. is the Chairman and CEO. The company has a typical corporate structure with a board of directors and executive management team overseeing various departments.
Top Products and Market Share
Key Offerings
- Gamma Knife: Provides Gamma Knife radiosurgery services. AMS is a major provider but market share data is limited, varies regionally and is not published publically. Competitors include Elekta and Varian Medical Systems.
- Proton Beam Therapy: Offers proton beam radiation therapy equipment and services. Market share data is very fragmented. Competitors include Ion Beam Applications (IBA) and Varian Medical Systems.
- Mobile Medical Systems: Providing and leasing advanced mobile and fixed-site medical systems. Competitors include medical equipment suppliers.
Market Dynamics
Industry Overview
The medical equipment leasing and radiosurgery market is driven by technological advancements, aging populations, and increasing demand for advanced cancer treatment. The healthcare industry is constantly evolving with new technologies and treatment methods.
Positioning
AMS positions itself as a provider of specialized and advanced medical technology solutions, particularly in radiosurgery and radiation therapy. Its competitive advantage lies in its specialized focus and established relationships with hospitals.
Total Addressable Market (TAM)
The TAM for medical equipment leasing and radiosurgery is estimated to be in the billions of dollars globally. AMS has a smaller market share but is targeting growth within its niche.
Upturn SWOT Analysis
Strengths
- Specialized expertise in radiosurgery and radiation therapy
- Long-standing relationships with hospitals and healthcare providers
- Focus on innovative medical technology
- Recurring revenue through equipment leasing and service agreements
Weaknesses
- Small market capitalization
- Dependence on a limited number of key customers
- High capital expenditure requirements
- Vulnerability to changes in healthcare regulations
Opportunities
- Expansion into new geographic markets
- Increased adoption of radiosurgery and radiation therapy
- Strategic partnerships with larger healthcare organizations
- Development of new medical technology solutions
Threats
- Competition from larger medical equipment companies
- Technological obsolescence
- Changes in reimbursement policies
- Economic downturns affecting hospital capital budgets
Competitors and Market Share
Key Competitors
- Elekta (EKTAY)
- Varian Medical Systems (Siemens Healthineers: SHLA.DE)
- Accuray (ARAY)
Competitive Landscape
AMS operates in a highly competitive market against much larger players. Its specialization is an advantage, but it lacks the scale and resources of its larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data unavailable
Future Projections: Future financial projections data unavailable
Recent Initiatives: Focus on Gamma Knife and proton beam services expansion.
Summary
American Shared Hospital Service is a niche player in the medical technology market, specializing in radiosurgery and radiation therapy. Its strengths lie in its expertise and relationships, but it faces challenges from larger competitors and capital requirements. Growth opportunities exist, but the company must manage its risks carefully. Overall, it's a small player in a competitive market that would likely see increased stability after being acquired by a larger company. AMS has a potential for growth but the small market cap hinders this ability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates (where available)
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Shared Hospital Service
Exchange NYSE MKT | Headquaters San Francisco, CA, United States | ||
IPO Launch date 1984-09-07 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 81 | Website https://ashs.com |
Full time employees 81 | Website https://ashs.com | ||
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments, Leasing and Retail. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.